Abstract: The present invention is directed toward a method for inhibiting COX-2 in an organism. In particular, the method is preferably directed toward selectively inhibiting COX-2 in an organism. The method comprises administering to the organism an organic extract isolated from a non-edible plant wherein such extract inhibits COX-2 . A method to purify a composition that exhibits COX-2 inhibition and COX-2 selective inhibition from the organic extract is also provided. In addition, a method for treating and/or preventing COX-2 mediated inflammation or inflammation-associated disorders in an organism is provided.

Abstract: Compositions and methods for treating eye discomfort and eye disease are provided. The compositions comprise singly or in combination herbals, natural nutritional supplements, minerals and vitamins. Methods of making these compositions are also provided.

Abstract: The present invention is directed toward a method for inhibiting COX-2 in an organism. In particular, the method is preferably directed toward selectively inhibiting COX-2 in an organism. The method comprises the step of administering to the organism an organic extract isolated from an edible plant wherein such extract inhibits COX-2 A method to purify a composition that exhibits COX-2 inhibition and COX-2 selective inhibition from the organic extract is also provided. In addition, a method for treating and/or preventing COX-2 mediated inflammation or inflammation-associated disorders in an organism is provided.

Abstract: The present invention relates to oral preparations, foods, drinks, feeds, food additives or feed additives having an itching-relieving or antipruritic activity which contain, as an active ingredient, plant body of a plant that belongs to the genus Matricaria or Anthemis or an extract of the plant body.

Abstract: Compositions and methods for preventing and treating cancer are provided that comprise extracts of Inula britannica or compounds isolated therefrom.

Abstract: This invention relates to compositions for the treatment of acquired immunodeficiency diseases, especially human immunodeficiency virus (HIV), and its simian and feline counterparts (simian immunodeficiency virus (SIV), and feline immunodeficiency virus (FIV)), and to methods for their use.

Abstract: The present invention relates to a diet composition comprising raw foods comprising the lyophilized powders of grains, vegetables and seaweeds; dietary fibers; and functional herbal extracts, etc. The composition according to the present invention is effective in reduction of weight and body fat and body shape management as well as abundant in nutrition ingredients. And also the composition has an excellent effect on decreasing cholesterol and neutral fat amounts in blood. Therefore, the composition according to the invention can be usefully employed as a food capable of preventing or improving obesity while assisting in ingesting nutriments, which are apt to be lacking in modern people, without omission.

Abstract: The present invention relates to an antibacterial composition, comprising as an active ingredient saponificated vegetable oil, preferably soybean oil, or one or more components thereof; and at least one carrier. Also a ready-to-use composition comprising a with water diluted composition and a process for the production of an above composition is disclosed. Use of a saponificated vegetable oil, preferably soybean oil, or one or more components thereof is disclosed. Additionally the present invention relates to a method for controlling bacteria on pests comprising the application of an anti-bacterially effective amount of an above composition onto said pests.

Abstract: Mixed zeaxanthin C8-C20 carboxylic acid esters in which the mixed zeaxanthin esters constitute about 50 mg/g or more of the concentrate and wherein the zeaxanthin is about 20 percent or more of the total carotenoids present when assayed after saponification are disclosed, as are the products that can be made from such a concentrate, as well as the several uses for mixed zeaxanthin esters.

Abstract: A mixed substance for treating hypertension and constipation, for detoxification, and for improving the immune system, produced by extracting arctium lappa L., carrot, and whole radish with water one or two hours at temperatures of 70° C.-100° C. under agitation, separating the extracts and solid by-products, vacuum condensing the extracts, lyophilizing condensed extracts to a powder using a low temperature, and encapsulating the powder or pressing the powder into tablets. Patients taking a daily dosage of this vegetable medicine have shown greatly improved health conditions.

Abstract: There is provided a moisturizing lotion composition for use on the skin. The composition comprises one or more milk protein compounds and one or more essential oils. The one or more milk protein compounds provide enhanced moisturizing to the skin while the one or more essential oils provide a calming effect to the user of the lotion.

Abstract: Whitening cosmetics contain (A) an oil-soluble chamomilla extract and (B) at least one oil selected from esters of carboxylic acids having 2 to 22 carbon atoms with alcohols having 1 to 22 carbon atoms and vegetable oils. These whitening cosmetics provide good feeling of use upon application, and moreover, are excellent in skin-whitening effect and can satisfactorily prevent formation of spots and freckles which result from sunburn.

Abstract: A process of making an osteopathy solution includes the steps of (a) soaking a raw composition which includes Radix Angelicae Sinensis, Radix Paeoniae Rubra, Rhizoma seu Radix Notopterygii, Radix Angelicae Dahuricae, Herba Asari, Folium Artemisiae Argyi, Radix Angelicae Pubescentis, Radix Dipsaci, Myrrha, Ramulus Mori, Radix Rubiae, Radix Clematidis, Radix Stephaniae Tetrandrae, Rhizoma Cimicifugae and Radix Gentianae Macrophyllae in a predetermined amount of water for a predetermined period of soaking time to form a pre-decocting solution and a pre-decocting composition; (b) heating the pre-decocting solution and the pre-decocting composition for a predetermined period of reaction time to form a mixture consisting of a residual composition and a solution; wherein a volume ratio of said solution in step (b) and said water in step (a) is approximately 1:3; and (c) cooling down the solution to a predetermined temperature.

Abstract: Nutritional compositions capable of reducing the risk of cancer are provided. The nutritional compositions combine the added effects of both a prebiotic source and a phytochemical(s) capable of inducing enzymatic activity in mammals to reduce the incidence of cancer. The prebiotic and phytochemical source can be derived from a single plant material, such as chicory.

Abstract: The present invention provides a composition for enhancing growth factor production, comprising a plant-derived enhancer for growth factor production; a therapeutic agent or prophylactic agent for a disease requiring enhancement of growth factor production and a food, beverage or feed for enhancing growth factor production, each comprising the above composition. In addition, the present invention relates to a functional food, beverage or feed excellent in health enhancement.

Abstract: A fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes is disclosed. The fatigue recovery medicine for changing in hepatic mRNA levels of stress-related genes is composed of: astragali radix of 13.2% by weight, atractylodis rhizoma alba of 8.8% by weight, angelicae gigantis radix of 8.8% by weight, longanae arillus of 8.8% by weight, lycii folium of 8.8% by weight, cridii rhizoma of 6.7% by weight, hoellen of 4.4% by weight, glycyrrhizae radix of 4.4% by weight, carthami flos of 4.4% by weight, cervi parvum cornu of 4.4% by weight, crataegi fructus of 4.4% by weight, rehmanniae radix preparata of 4.4% by weight, saussureae radix of 4.4% by weight, amomi fructus of 4.4% by weight, polygony multiflori radix of 4.4% by weight, paeoniae radix alba of 4.4% by weight and ginseng radix of 4.4% by weight.

Abstract: This invention provides compositions and methods related to the administration of deer antler, one or more nor-testosterone precursors, and one or more testosterone precursors, to increase testosterone levels, treat sexual dysfunction, improve sexual function, improve energy, enhance feelings of well-being and increase muscle mass in males. This invention also provides for inhibitors of the enzymes aromatase and/or 5-alpha reductase, to support testosterone levels and avoid undesirable metabolites.

Abstract: 27-deoxyactein form is provided in high purity using a multi-step process. The plant of the Cimicifuga genus (e.g., the root portion) is contacted with an organic solvent to extract certain components, including triterpene glycosides, from that plant. The resulting extracted portion is subjected to a reduction step to convert some of the triterpene glycosides to 27-deoxyactein. The 27-deoxyactein is then isolated, preferably by chromatographic techniques. The present invention also provides a therapeutic composition comprising a therapeutically effective amount of the isolated 27-deoxyactein according to the above method.

Abstract: This present invention describes a method of diagnosing and treating neuropathic pain, Bell's palsy, viral sore throat, pain due to burns, including sunburn, and pain and itching due to insect bites with compositions of essential aromatic oils, all of which contain Pelargonium graveolens (also called geranium oil bourbon or GOB). This invention discloses compositions of one or more of five other essential aromatic oils, particularly lavender, bergamot, blue chamomile, eucalyptus and tea tree, which when added to GOB acts synergistically with the GOB. These compositions can be used alone or in a composition with a pharmaceutically acceptable carrier in topical or oral dosage form. The present invention is an improvement in the methods and expansion of uses as stated in the previous United States Patent issued in 1993 entitled “Diagnosis and Treatment of Various Neuralgias” (Frome)—U.S. Pat. No. 5,260,313.

Abstract: The present invention relates to a composition for the treatment of acne comprising chlorine dioxide or chlorine dioxide generating compounds as acne reduction agents. The invention also relates to a method for treating acne by topically administering one of the compositions in an amount therapeutically effective to reduce the redness and blemishes associated with acne.

Abstract: Triterpene glycosides are provided in using a multi-step process. The plant of the Cimicifuga genus (e.g., the root portion) is contacted with an organic solvent to extract certain components, including triterpene glycosides, from that plant. The resulting extracted portion is subjected to a reduction step to convert some of the triterpene glycosides to compounds such as 27-deoxyactein. Optionally, compounds such as 27-deoxyactein then are isolated, preferably by chromatographic techniques. The present invention also provides a therapeutic composition comprising a therapeutically effective amount of the triterpene glycosides provided according to the above method.

Abstract: Topical analgesics, generally comprising calendula oil and cornmint oil, and methods of use.

Abstract: Compositions and methods are provided for aiding human beings to complete emptying of the bladder, to reduce urination frequency, to alleviate the urgency and difficulty in postponing urination, to lessen the interruption in urinating, to increase the urinary stream flow, to facilitate the beginning of urination, to reduce nocturia, or to increase libido. These advantages are achieved by administering to a human being a preparation with at least a part of at least one plant in family Asteraceae. Preparations from a part of the plant Wyethia amplexicaulis are preferred. Other examples of suitable plants include Balsamorhiza sagittata, Helianthella uniflora, and Tragopogon dubius. The treatment composition may include parts of the plants or an active agent obtained from one of these plants and isolated or a synthetic equivalent.

Abstract: An ATP synthesis activator is provided, which allows the promotion of ATP synthesis in the body and results in an increased ATP level in the body for a long period of time. The ATP synthesis activator comprises, as an active ingredient, a mixture of a plurality of herbs having an ion-exchange capacity. It may stimulate electron generation in the body and hence results in an improved ATP synthesis activity due to the generated electrons, because dietary fiber contained in the herbs has an ion-exchange capacity. Preferably, the herb mixture includes thyme, rosemary, turmeric, fennel, grape seeds, dandelion, and Acanthopanax senticosus. Also the composition is useful for treating immune deficiency diseases.

Abstract: A process for preparing dry extracts from a liquid extract and at least one additional substance by a spray-drying process, characterized in that said at least one additional substance is added to the spray-drying process in a dry form during the spray-drying processes.

Abstract: This invention provides compositions and methods related to the administration of deer antler, one or more nor-testosterone precursors, and one or more testosterone precursors, to increase testosterone levels, treat sexual dysfunction, improve sexual function, improve energy, enhance feelings of well-being and increase muscle mass in males. This invention also provides for inhibitors of the enzymes aromatase and/or 5-alpha reductase, to support testosterone levels and avoid undesirable metabolites.

Abstract: An object of the present invention is to provide a pharmaceutical agent or composition useful as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction, motor paralysis, diminution of vision, hepatitis, inflammatory intestinal syndrome, functional enteropathy, functional cardiopathy, functional hepatopathy, functional nephropathy, dementia, climacteric symptoms, senile dementia and/or Alzheimer disease, and a dermatological agent or composition suitable for skin applications, which can treat or prevent muscle weakening and inflammation, in particular arthritis, by its muscle-strengthening and/or anti-inflammatory actions, said agent or composition comprising isoflavone and/or isoflavone glycoside in combination with a pungent substance, a bitter substance or a sour substance, and cholic acid, and/or scymnol and/or a scymnol ester.

Abstract: This invention provides compositions and methods related to the administration of deer antler, one or more nor-testosterone precursors, and one or more testosterone precursors, to increase testosterone levels, treat sexual dysfunction, improve sexual function, improve energy, enhance feelings of well-being and increase muscle mass in males. This invention also provides for inhibitors of the enzymes aromatase and/or 5-alpha reductase, to support testosterone levels and avoid undesirable metabolites.

Abstract: Compositions comprising long-chain organic molecules obtained from natural oils, particularly plant, bean, seed and nut oils, and their derivatives can be provided with increased oxygen stability by their combination with mixtures of particular classes of antioxidants, particularly combinations of at least one synthetic free-radical terminating antioxidant. The stabilization combination is particularly effective in combination with long-chain oils having less than 5% methylene interrupted unsaturation. The long-chain oil may comprise a natural oil or wax. The long-chain oil may have a percent methylene interrupted unsaturation of less than 5%, less than 3%, or less than 1%. The emollient composition may have at least one supplemental additive, which is a reducing agent present in an amount of from 0.01 to 5% or more by weight of said long-chain oil and the free-radical terminating antioxidant is present in an amount of from 0.01 to 5% by weight of said long-chain oil.

Abstract: The present invention provides methods and compositions for the stimulation of immune responses. Specifically, the present invention provides methods and compositions for the use of nanoemulsion compounds as mucosal adjuvants to induce immunity against environmental pathogens. Accordingly, in some embodiments, the present invention provides nanoemulsion vaccines comprising a nanoemulsion and an inactivated pathogen or protein derived from the pathogen. The present invention thus provides improved vaccines against a variety of environmental and human-released pathogens.

Abstract: The present invention is related to a crude drug composition essentially comprising herbs of Sinapis Semen Alba, Ginseng Radix, Zingiberis Rhizoma Siccus, Amomi Fructus, Myristicae Semen, Saussureae Radix, Cyperi Rhizoma, Magnoliae Cortex, Arecae Semen, Crataegi Fructus, Atractylodes Rhizoma Alba, Agastachis Herba, Glycyrrhiza Radix and additionally comprising at least one herb selected from group consisting of Polygonati Rhizoma, Artemisiae Argyi Folium, Forsythiae Fructus, Caryophylli Flos, Raphani Semen, Menthae Herba according to the need for the prevention and treatment of gastrointestinal dyskinetic diseases and methods of using the above crude drug composition and pharmaceutical composition as prokinetic agent.

Abstract: The present invention relates to effervescent compositions containing active ingredients, in particular dry plant extracts, wherein the acid donor of the effervescent couple is constituted by a dried fruit juice with a natural acid pH, such as freeze-dried citrus fruit juice.

Abstract: Provided by the invention are systems for applying diaper rash treatment compositions to a selected skin treatment area without the need for the person administering the treatment to directly contact the composition or the skin of the patient. Application of the diaper rash treatment composition is accomplished by forming the composition into a mist or spray using an atomizing spray dispenser.

Abstract: Compositions and methods for preventing and treating cancer are provided that comprise extracts of Inula britannica or compounds isolated therefrom. The compounds of 1-O-acetylbritannilactone or 1,6-O,O-diacetylbritannilactone are isolated and used for inducing apoptosis in cells and for treating cancer in an animal. Induction of apoptosis comprises contacting cells with a composition comprising the compounds in an amount sufficient to induce Bcl-2 protein phosphorylation. Further, treatment of cancer in an animal comprises administering to an animal a composition comprising the compounds in an amount sufficient to induce Bcl-2 protein phosphorylation to treat the cancer.

Abstract: The invention relates to the use as a sebum regulating agent of a hydrolysed vegetable protein produced by enzymatic hydrolysis, and to compositions comprising a hydrolysed vegetable protein produced by enzymatic hydrolysis for application to the skin to inhibit or regulate sebum production, to inhibit or treat oily skin, or to prevent, inhibit or treat acne. The vegetable protein may be for example a cereal protein such as soy protein, wheat protein or an extract from a tree such as cedar, poplar or mimosa, or from the foliage or from the various stages of the flower, such as the bud. Preferably the vegetable protein has a molecular weight in the region of 100,000 to 500,000 Daltons.

Abstract: Compositions in gel form or suppository are provided for treatment of vaginal dryness, wherein the composition comprises certain herbal compounds, with or without a vitamin such as, for example, vitamin A, C, D or E. The compositions may include an anti-bacterial agent and are applied to the affected area in an amount which is effective to provide the required relief when applied over a period of time.

Abstract: Suspensions, emulsions or dispersions of therapeutically active agents which are water insoluble or water intolerant such as nutritional supplements, herbal products, drugs, bacteria, yeast, vitamins and minerals are prepared as suspensions in edible vegetable oils such as orange, lemon, soybean, cotton seed, peanut, canola corn oil, sunflower, safflower, palm kernel, palm and coconut. The active therapeutic agent may be in crystalline or amorphous form, it may be a liquid as for example an oil such as vitamin B or beta carotene, or a preparation of a comminuted plant structure such as flower, parts, leaf; stern, root or tree bark, or an extract of a dried plant structure or a freeze dried preparation of a vital bacteria or yeast. The suspension is formed by active mixing of the active agent and oil.

Abstract: The present invention relates to cosmetic compositions that may be topically applied to skin, hair and nails for improving the aesthetic appearance thereof. The present invention also relates to compositions that may be topically applied to skin, hair and nails for ameliorating, forestalling, reducing, preventing, and/or treating the signs of aging due to extrinsic and/or intrinsic factors.

Abstract: Nose ointment for the prophylaxis of inhalation allergic reactions comprising at least one mixture of saturated hydrocarbons characterized in that the at least one mixture of saturated hydrocarbons has a viscosity by the DIN 51 562 method of >6 mm2/s (100° C.).

Abstract: An injectable bone mineral substitute material composition comprises an inorganic bone cement powder and a biologically compatible oil. The oil is an intermixture with the cement powder at a concentration of less than 10 wt % of the total weight of the composition in order to improve the rheology of the same. In a method of intermixing a powder of an implant material and a biologically compatible oil to a composition the oil is mixed with the powder of implant material at an elevated temperature.

Abstract: There is provided a method of preparing an unsaturated fatty acid dry concentrate, wherein a substance comprising at least one unsaturated fatty acid is applied on a biologically inert matrix having a large surface area and is subsequently dried, as well as a composition comprising at least one unsaturated fatty acid and foods, beverages, drugs comprising this composition.

Abstract: There is provided a method for treating diseases such as fibromyalgia and diabetic neuropathy by the topical application of a composition comprising plant extracts. The composition contains a lymphatic activity or and a mobilizer of white blood cell activity and a vasodilator.

Abstract: A topical composition and method for the treatment of the symptoms of diaper rashes and skin irritations by creating an air circulating mechanism comprising a) bicarbonate of soda; b) corn starch; c) citric acid; d)a carrier oil; e) a pharmaceutically acceptable moisturizer, f) fragrance oil; and g) food grade coloring. The carrier oil is selected from the group consisting of almond oil, coconut ail, sunflower oil, apricot kernel oil, avocado oil, canola oil, evening primrose oil, grapeseed oil, hazelnut oil, jojoba oil, macadamia oil, dive oil, sesame oil, rosehip seed oil, and mixtures thereof. The pharmaceutically acceptable moisturizer is either purified water or witch hazel. In its preferred embodiments, the composition can result in a loose powder for application directly to the diapered skin, an effervescent bath tablet, and as an additive to the bodyfacing layer of a diaper.

Abstract: A fabrication method of an oral care composition comprising the steps of drying a Cimicifuga root, soaking the dried Cimicifuga root in a vinegar for a predetermined time period, and drying the vinegar-soaked Cimicifuga root. The vinegar-soaked then dried Cimicifuga root, a salt and a water are admixed at a sequential weight ratio of about 10% to 40%, about 10% to 40% and about 30% to 50%. The admixture of the Cimicifuga root, the salt and the water are evaporated to obtain a Cimicifuga-salt concentration and then Cinicifuga root fibers are removed from the Cimicifuga-salt concentration.

Abstract: The present invention provides a method for treating patients with liver diseases by co-administrating a pharmaceutical composition and lamivudine to the patients. The pharmaceutical composition is a herbal mixture which contains, as the core ingredients, the aqueous extracts of the entire plant of Herba Hedyotidis diffusae, the rhizome of Rhizoma Bistortae, the rhizome of Rhizoma Polygoni Cuspidati, and the ripe fruit of Fructus Schisandrae. The present invention also provides methods for preventing a relapse of hepatitis in patients after the lamivudine treatment has been discontinued and for suppressing the development of lamivudine drug resistance in patients by providing the lamivudine-treated patients with the pharmaceutical composition of the present invention.

Abstract: The present invention provides a skin care product comprising whole egg, an emollient substance and a humectant substance, colostrum, lactoferrin and/or methyl sulfonyl methane (MSM).

Abstract: A marigold plant, a regenerable portion thereof and seed are disclosed whose flower petals, leaves or flower petals and leaves contain one or more of an enhanced zeaxanthin ratio, an enhanced neoxanthin plus violaxanthin ratio, an enhanced &bgr;-carotene ratio, an enhanced &agr;-cryptoxanthin ratio, an enhanced phytoene ratio or an enhanced phytofluene ratio relative to that ratio in a non-mutant marigold. The flower petals of such a plant also typically contain zeta-carotene that is not normally found in such petals. Also disclosed are methods of preparing such plants, oleoresins and comestible materials that have such carotenoid ratios.

Abstract: The present invention advances prior art intensive repair serums by providing an intensive repair serum formulated with Morinda citrifolia from the Indian Mulberry plant. The addition of Morinda citrifolia to the serum of the present invention serves to provide significant skin care advantages not found in prior art intensive repair serums.

Abstract: A liquid dietary supplement useful in increasing bodily levels of coenzyme Q10 is disclosed. The supplement comprises an oil in water emulsion of coenzyme Q10. The dietary supplement disclosed is pleasant tasting, is effectively absorbed into the body and is believed to provide substantial therapeutic effects.

Abstract: Disclosed is a method of preparing an extract of the herb sea buckthorn. In the absence of oxygen and metals berries of sea buckthorn are mixed with a vegetable oil and the mixture is incubated, which results in the extraction of liposoluble components of the berries into the vegetable oil. The extract is then separated from the berries. A composition is prepared of about 5 to about 95 wt % of the extract, 0 to about 95 wt % of an extract of a herb selected from the group consisting of rose hips (Rosa species), St. John's wort (Hypericus perforatum), chickweed herb (Stellaria media), plantain herb (Plantago major), calendula flowers (Calendula officinalis), and mixtures thereof, prepared by extracting liposoluble components of the herb into a vegetable oil in the absence of oxygen and metal, 0 to about 10 wt % of an essential oil, 0 to about 15 wt % of an antioxidant, and 0 to about 80 wt % of a diluent. The composition is applied to open skin lesions to promote their healing.